| Company name | Gilead Sciences, Inc. |
| Stock ticker | GILD |
| Live stock price | [stckqut]GILD[/stckqut] |
| P/E compared to competitors | Good |
MANAGEMENT EXECUTION
| Employee productivity | Good |
| Sales growth | Good |
| EPS growth | Good |
| P/E growth | Poor |
| EBIT growth | Good |
ANALYSIS
| Confident Investor Rating | Good |
| Target stock price (TWCA growth scenario) | $84.36 |
| Target stock price (averages with growth) | $57.48 |
| Target stock price (averages with no growth) | $44.01 |
| Target stock price (manual assumptions) | $325.94 |
The following company description is from Google Finance: https://finance.google.com/finance?q=gild
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company’s portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.
Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Gilead Sciences, Inc. as long as the indicators that I describe in my book The Confident Investor are favorable. I am adding Gilead Sciences to my list.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.
How was this analysis of Gilead Sciences, Inc. calculated?
For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:
- Stock price at the time of the calculation: $71.64
- Growth: 0.2
- Current EPS (TTM): $8.79
- P/E: 24
- Future EPS Calc: $21.87
- Future Stock Price Calc: $524.93
- Target stock price: $325.94
[/s2If]
I hope that this makes you a Confident Investor.